Clinical Trial Update: Comparison of Efficacy and Safety of Ceftazidime Avibactam Versus Extended Infusions of High Dose Meropenem in Patients of ACLF With Nosocomial Infections. [NA]

View source ↗

Summary

A clinical trial evaluating the efficacy and safety of ceftazidime-avibactam versus extended-infusion high-dose meropenem for nosocomial infections in patients …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• On Chronic Liver Failure

Drugs mentioned

• Meropenem (Meropenem)
• ceftazidime/avibactam (ceftazidime/avibactam)

Snippet

Sponsor: Institute of Liver and Biliary Sciences, India | Conditions: Acute-On-Chronic Liver Failure | NA | Status: NOT_YET_RECRUITING